Team:Berkeley/Parts
From 2011.igem.org
(Difference between revisions)
Line 52: | Line 52: | ||
<div class="row-end" ></div> | <div class="row-end" ></div> | ||
</div> | </div> | ||
+ | |||
<div class="row"> | <div class="row"> | ||
<div class="col12-2"> | <div class="col12-2"> | ||
Line 80: | Line 81: | ||
<div class="row-end" ></div> | <div class="row-end" ></div> | ||
</div> | </div> | ||
+ | |||
+ | <div class="row"> | ||
+ | <div class="col12-2"> | ||
<h3>Function</h3> | <h3>Function</h3> | ||
Line 99: | Line 103: | ||
<h3>Notes</h3> | <h3>Notes</h3> | ||
+ | </div> | ||
+ | <div class="row-end" ></div> | ||
+ | </div> | ||
+ | |||
+ | <div class="row"> | ||
+ | <div class="col12" id="spacer3"></div> | ||
+ | <div class="row-end"> </div> | ||
+ | </div> | ||
+ | |||
+ | |||
+ | <div class="row"> | ||
+ | <div class="col12-2"> | ||
<br><br> | <br><br> | ||
Line 115: | Line 131: | ||
<h3>Notes</h3> | <h3>Notes</h3> | ||
+ | |||
+ | <div class="row"> | ||
+ | <div class="col12" id="spacer3"></div> | ||
+ | <div class="row-end"> </div> | ||
+ | </div> | ||
+ | |||
<br><br> | <br><br> | ||
<h1>Reporter Plasmid (banner)</h1> | <h1>Reporter Plasmid (banner)</h1> | ||
+ | |||
+ | |||
+ | <div class="row"> | ||
+ | <div class="col12-2"> | ||
<h3>Function</h3> | <h3>Function</h3> | ||
Line 137: | Line 163: | ||
<h3>Notes</h3> | <h3>Notes</h3> | ||
+ | |||
+ | <div class="row"> | ||
+ | <div class="col12" id="spacer3"></div> | ||
+ | <div class="row-end"> </div> | ||
+ | </div> | ||
<br><br> | <br><br> | ||
<h1>Estrogen Receptor - ToxR chimera (banner)</h1> | <h1>Estrogen Receptor - ToxR chimera (banner)</h1> | ||
+ | |||
+ | <div class="row"> | ||
+ | <div class="col12-2"> | ||
<h3>Function</h3> | <h3>Function</h3> | ||
Line 157: | Line 191: | ||
<h3>Notes</h3> | <h3>Notes</h3> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
Line 244: | Line 197: | ||
<div class="row-end"> </div> | <div class="row-end"> </div> | ||
</div> | </div> | ||
+ | |||
</div> | </div> | ||
</html> | </html> |
Revision as of 19:27, 25 September 2011
# of parts submitted:
Assembly Standard: BglBricks
Accomplishments:
- 35 Regulatory promoters
- 2 Ribosome Binding Sites
- 1 Reporter device
- 3 Composite expression modules
- 2 Coding proteins
Assembly Standard: BglBricks
Accomplishments:
Function
Stress promoters respond differently to various types of stress that is placed on the cell. We wanted a promoter that would be downregulated in the presence of membrane stress caused by the over expression of ToxR. The design principle is to express ToxR under the control of this promoter such that the stress it causes drives negative feedback on its own production.Assembly
The 34 stress promoters were PCRed from E. Coli MC1061 Genomic DNA. Basic parts were made in plasmids with pUC origins. A constitutive promoter (Pcon) was also cloned into a basic part as a control for characterization.Characterization
Explanation of experiments! GRAPH!!!!Experiments
GRAPH!!!!